Loading clinical trials...
Loading clinical trials...
ELU42 01 01 (SuperHealer42) is a Phase I/IIA open label study sponsored by Eluciderm, Inc. that evaluates the safety and preliminary effectiveness of ELU42, a topical small molecule designed to modula...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Eluciderm Inc
NCT06383013 · Diabetic Foot Ulcer
NCT07541196 · Diabetic Foot Ulcer (DFU), Pressure Ulcer (PU), and more
NCT07039396 · Diabetic Foot Ulcer
NCT06449638 · Diabetic Foot Ulcer (DFU), Ulcer Foot, and more
NCT07116876 · Diabetic Foot Ulcer (DFU), Lower Extremity
Gateway Clinical Trials
O'Fallon, Illinois
Independent Clincal Research LLC
Springfield, Illinois
Curalta Clinical Trials
Oradell, New Jersey
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions